Semaglutide Pen
5 mg per pen
Prefilled injection pen
Manufacturer: Hilma Biocare
€130.00
-
Worldwide Delivery
-
Payment
Description
Semaglutide Pen 5mg
The Semaglutide Pen contains a ready mixed GLP-1 receptor agonist solution. Its prefilled presentation holds 5 mg in 3 ml, distinguishing it from the lyophilized vial format.
Product specifications
| Property | Product information |
|---|---|
| Active substance | Semaglutide |
| Class | GLP-1 receptor agonist |
| Presentation | Prefilled pen containing injectable solution |
| Total pen content | 5 mg |
| Volume | 3 ml |
| Indicative half life | Approximately 1 week |
GLP-1 signalling and satiety
Semaglutide mimics GLP-1 activity, slowing gastric emptying and reducing hunger and cravings. Its described applications include sustained weight changes through appetite and metabolic regulation, including users whose routine does not involve exercise.
- Appetite and craving reduction
- Slower gastric emptying
- Blood glucose regulation
- Sustained weight management effects
Usage and administration
The described profile includes weekly subcutaneous administration and gradual dose adjustment to limit nausea. Its numerical range of 1–3 mg per week is described in its administration context; the product content in the specifications is a separate quantity.
Related products and comparisons
The lyophilized Semaglutide vial is the other presentation in the product catalogue. Tirzepatide and Retatrutide provide the dual- and triple receptor comparisons described in its description.
Health and usage information
This page provides educational information about the product to help you make informed choices. It does not replace medical advice. If you have a health condition or questions about dosage, consult a sports medicine doctor or another healthcare professional.









Reviews
There are no reviews yet.